Literature DB >> 1712938

Termination of transcription in an 'in vitro' system is dependent on a polyadenylation sequence.

V J Miralles1.   

Abstract

Using HeLa cell nuclear extract as a source of the different transcription and polyadenylation factors and reverse transcription to analyze the levels of RNA 5' and 3' to the cleavage-polyadenylation site, an in vitro assay has been established to study polyadenylation coupled to transcription directed by different adenovirus promoters. The levels of transcription 5' and 3' to the cleavage site in the L3 polyadenylation region are practically the same as described previously, however, the level of transcription 3' to the cleavage site in the SV40 early polyadenylation region decreases immediately after the cleavage site indicating a termination of the transcription.

Mesh:

Substances:

Year:  1991        PMID: 1712938      PMCID: PMC328384          DOI: 10.1093/nar/19.13.3593

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  47 in total

1.  An ordered pathway of assembly of components required for polyadenylation site recognition and processing.

Authors:  G M Gilmartin; J R Nevins
Journal:  Genes Dev       Date:  1989-12       Impact factor: 11.361

2.  Two phases in the addition of a poly(A) tail.

Authors:  M D Sheets; M Wickens
Journal:  Genes Dev       Date:  1989-09       Impact factor: 11.361

3.  The AAUAAA sequence is required both for cleavage and for polyadenylation of simian virus 40 pre-mRNA in vitro.

Authors:  D Zarkower; P Stephenson; M Sheets; M Wickens
Journal:  Mol Cell Biol       Date:  1986-07       Impact factor: 4.272

4.  A poly(A) addition site and a downstream termination region are required for efficient cessation of transcription by RNA polymerase II in the mouse beta maj-globin gene.

Authors:  J Logan; E Falck-Pedersen; J E Darnell; T Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

5.  5'-Terminal structure and mRNA stability.

Authors:  Y Furuichi; A LaFiandra; A J Shatkin
Journal:  Nature       Date:  1977-03-17       Impact factor: 49.962

6.  Poly(A) polymerase purified from HeLa cell nuclear extract is required for both cleavage and polyadenylation of pre-mRNA in vitro.

Authors:  G Christofori; W Keller
Journal:  Mol Cell Biol       Date:  1989-01       Impact factor: 4.272

7.  3' cleavage and polyadenylation of mRNA precursors in vitro requires a poly(A) polymerase, a cleavage factor, and a snRNP.

Authors:  G Christofori; W Keller
Journal:  Cell       Date:  1988-09-09       Impact factor: 41.582

8.  Analysis of RNA cleavage at the adenovirus-2 L3 polyadenylation site.

Authors:  C L Moore; H Skolnik-David; P A Sharp
Journal:  EMBO J       Date:  1986-08       Impact factor: 11.598

9.  Alpha-thalassaemia caused by a poly(A) site mutation reveals that transcriptional termination is linked to 3' end processing in the human alpha 2 globin gene.

Authors:  E Whitelaw; N Proudfoot
Journal:  EMBO J       Date:  1986-11       Impact factor: 11.598

10.  A rabbit beta-globin polyadenylation signal directs efficient termination of transcription of polyomavirus DNA.

Authors:  J Lanoix; N H Acheson
Journal:  EMBO J       Date:  1988-08       Impact factor: 11.598

View more
  4 in total

1.  Mechanism of poly(A) signal transduction to RNA polymerase II in vitro.

Authors:  D P Tran; S J Kim; N J Park; T M Jew; H G Martinson
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

2.  Regulated adenovirus mRNA 3'-end formation in a coupled in vitro transcription-processing system.

Authors:  S I Wilson-Gunn; J E Kilpatrick; M J Imperiale
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

3.  3' Processing and termination of mouse histone transcripts synthesized in vitro by RNA polymerase II.

Authors:  X Gu; W F Marzluff
Journal:  Nucleic Acids Res       Date:  1996-10-01       Impact factor: 16.971

Review 4.  Plant mRNA 3'-end formation.

Authors:  H M Rothnie
Journal:  Plant Mol Biol       Date:  1996-10       Impact factor: 4.076

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.